课题基金 / 基金详情

项目摘要

项目成果

CHEMYONG JAY KO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY / ABSTRACT This study aims to test the hypothesis that an ESR1-expressing cell can be converted to an ESR2-expressing cell and investigate the molecular mechanism that controls the switch. 17β−estradiol (E2) is the key sex hormone regulating development and function of reproductive organs. While two estrogen receptors, ESR1 and ESR2, are well known to be responsible for the classical actions of E2, recent investigations into the functional role of ESR2 show that E2 elicits physiological responses from ESR2-expressing cells that are often completely opposite to those from ESR1-expressing cells. Importantly, while ESR1- and ESR2-expressing cells are co-existent in most of estrogen-responsive organs or tissues, ESR1 and ESR2 are expressed in different cell types. For example, ESR1 is expressed in the surface epithelium and theca cells in the ovary, whereas ESR2 is expressed exclusively in the granulosa cells (GC). No ovarian cell expresses both receptors. We recently made an unexpected observation during a characterization of a transgenic mouse line (Esr1iCreEsr2flox/flox) in which the Esr2 gene was designed to be ablated by a Cre recombinase whose expression was regulated by the endogenous Esr1 gene promoter. In other words, in this transgenic mouse line, the Esr2 gene was deleted in the ESR1 lineage cells. Surprisingly, we found that these transgenic mice were completely deficient of ESR2 expression in the granulosa cells, which otherwise express ESR2 abundantly. This finding indicates that GC lineage cells express ESR1 for some period prior to beginning to express ESR2, evidence of a conversion of ESR1 to ESR2 in the GC lineage. In this study, we will determine exactly when the ESR1 to ESR2 conversion occurs and what underlying mechanism controls the ESR1 and ESR2 expression, using novel transgenic mouse lines that the PI's laboratory generated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Endothelin-2 in Ovarian Follicle Rupture
  • 批准号:
    7572871
  • 项目类别:
  • 资助金额:
    $23.14万
  • 财政年份:
    2006
  • 负责人:
    CHEMYONG JAY KO
  • 依托单位:
Endothelin-2 in Ovarian Follicle Rupture
  • 批准号:
    7232265
  • 项目类别:
  • 资助金额:
    $23.61万
  • 财政年份:
    2006
  • 负责人:
    CHEMYONG JAY KO
  • 依托单位:
Endothelin-2 in Ovarian Follicle Rupture
  • 批准号:
    7077104
  • 项目类别:
  • 资助金额:
    $24.31万
  • 财政年份:
    2006
  • 负责人:
    CHEMYONG JAY KO
  • 依托单位:
Endothelin-2 in Ovarian Follicle Rupture
  • 批准号:
    7393644
  • 项目类别:
  • 资助金额:
    $23.14万
  • 财政年份:
    2006
  • 负责人:
    CHEMYONG JAY KO
  • 依托单位:
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: